EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General

    137 Aufrufe 137 0 Kommentare 0 Kommentare

    Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Edwards Lifesciences Corporation (“the Company”) (NYSE: EW).

    On July 24, 2024, the Company announced its financial results for the second quarter of the Fiscal Year ended December 31, 2024 disclosing disappointing results, specifically that the Company slashed its full-year revenue guidance for the Company’s core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform due to “continued growth and expansion of structural heart therapies … [which] put pressure on hospital workflows.”

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Edwards Lifesciences Corp!
    Short
    76,19€
    Basispreis
    0,59
    Ask
    × 11,37
    Hebel
    Zum Produkt
    Long
    67,47€
    Basispreis
    0,76
    Ask
    × 8,96
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing.

    KSF’s investigation is focusing on whether Edwards’ officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

    If you have information that would assist KSF in its investigation, or have been a long-term holder of Edwards shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-ew/ to learn more.

    About Kahn Swick & Foti, LLC

    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago and New Jersey.

    To learn more about KSF, you may visit www.ksfcounsel.com.


    The Edwards Lifesciences Stock at the time of publication of the news with a raise of +0,09 % to 68,99EUR on NYSE stock exchange (24. Januar 2025, 23:05 Uhr).

    Diskutieren Sie über die enthaltenen Werte



    Business Wire (engl.)
    0 Follower
    Autor folgen

    EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Edwards Lifesciences Corporation (“the Company”) (NYSE: EW). On …